Medical Research Council Technology, the commercialisation arm of the MRC, is negotiating with the Chinese government to make use of hundreds of soon-to-be out of work UK pharmaceutical researchers.
According to the Financial Times, the deal would entail the UK-based clinical research organisation, Dynasty, hiring specialists left jobless by high-profile closures of R&D sites, including Pfizer’s lab in Sandwich, Kent.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.